Minneapolis Veterans Medical Center
Minneapolis, Minnesota 55417
0 studies enrolling now · 11 studies all time
What they study most
Adenocarcinoma of the Colon, Adenocarcinoma of the Prostate, Adenocarcinoma of the Rectum, Chemotherapeutic Agent Toxicity, Clear Cell Renal Cell Carcinoma, Colorectal Cancer, Hormone-resistant Prostate Cancer, Kidney Cancer, Neuropathy, Neurotoxicity Syndrome, Pain, Prostate Adenocarcinoma
Studies at this site
- Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer — Completed
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery — Completed
- S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer — Completed
- S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery — Completed
- Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer — Status unconfirmed
- Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer — Stopped early
- Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy — Stopped early
- Bortezomib and Lenalidomide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma — Completed
- Green Tea Extract in Treating Patients With Nonmetastatic Bladder Cancer — Completed
- Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer — Completed
- Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer — Completed